Get the Weekly Intelligence Brief — top committee picks every Sunday.

LQDA vs RARE

Liquidia Corporation vs Ultragenyx Pharmaceutical Inc. — AI-powered side-by-side comparison
LQDA
Liquidia Corporation
68
Buy
VS
RARE
Ultragenyx Pharmaceutical Inc.
56
Watch
MetricLQDARARE
AI Score 68 56
Price $88.09 $26.96
P/E Ratio 368.26× -4.62×
ROE -154.0% 718.8%
Revenue Growth YoY
Gross Margin 91.8% 83.1%
Debt / Equity 1.70× -4.13×
Dividend Yield 0.0% 0.0%
RSI (14) 55.0 54.3
Beta 0.572 0.313
Expected Upside

AI Committee View

Current Innellis committee reasoning for LQDA versus RARE.
LQDA leads by 12 points.

LQDA scores 68/100 (Buy) versus RARE at 56/100 (Watch).

LQDA Committee View
67% agreement
6 analysts

The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.

Bull Case
  • ROE of 46.8% shows genuine earnings power backing the valuation — Value
  • Revenue growing 1936.7% YoY -- genuine top-line momentum — Growth
  • Price structure making higher highs and higher lows — Technical
Bear Case
  • P/E of 362.9 is expensive by classic value standards — Value
  • Price-to-book of 12.9x prices in significant intangible value — Value
  • MACD histogram negative -- bearish momentum — Technical
RARE Committee View
50% agreement
4 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 27.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (downtrend) confirms the daily trend -- multi-timeframe agreement — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • Price structure making lower highs and lower lows — Technical
  • Price structure (HH_HL) contradicts the downtrend -- mixed signals — Technical
  • Bollinger bandwidth of 27.5% signals elevated volatility — Risk
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
LQDA Full Analysis RARE Full Analysis